Risk factors associated with venous thromboembolism in rheumatoid arthritis in clinical practice
In this study of RA patients, history of VTE and recent hospitalisation were identified as strong risk factors of VTE. Moreover, it emphasises the importance of evaluating cardiovascular risk factors, particularly diabetes, for both arterial and venous thromboembolism risks. Finally, JAKi should be used with caution in patients with risk factors for VTE, as recommended by the Pharmacovigilance Risk Assessment Committee and the French Society of Rheumatology.
Authors
- M. Thomas (ORCID: https://orcid.org/0000-0001-6340-2275)
- Anna Moltó (ORCID: https://orcid.org/0000-0003-2246-1986)
- Yannick Allanore (ORCID: https://orcid.org/0000-0002-6149-0002)
- F. Oudart
- Alice Combier (ORCID: https://orcid.org/0000-0002-2945-3703)
- Jérôme Avouac (ORCID: https://orcid.org/0000-0002-2463-218X)
Institutions
- Université Paris Cité (FR)
- Hôpital Cochin (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
Publication Details
- Journal
- Clinical and Experimental Rheumatology
- Published
- 2024-12-26
- DOI
- https://doi.org/10.55563/clinexprheumatol/7r3hxm
- Primary Topic
- Venous Thromboembolism Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00